The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

A vaccine in the Respiratory Syncytial Virus Infection pipeline presents a cost-effective solution to reducing the burden of RSV, as current options for both prevention and treatment are limited ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

RSV can lead to a severe lung infection called bronchiolitis, which is dangerous in babies and can result in them being ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Respiratory ...

New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to ...

French pharmaceutical company Sanofi said it is acquiring London-based Vicebio to expand its range of respiratory virus ...